{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:32:19Z","timestamp":1793935939816,"version":"4.8.0"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T00:00:00Z","timestamp":1683676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00745"],"award-info":[{"award-number":["PI22\/00745"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004435","name":"Universidad de Navarra","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004435","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Obesity is a complex disease that relapses frequently and associates with multiple complications that comprise a worldwide health priority because of its rising prevalence and association with numerous complications, including metabolic disorders, mechanic pathologies, and cancer, among others. Noteworthy, excess adiposity is accompanied by chronic inflammation, oxidative stress, insulin resistance, and subsequent organ dysfunction. This dysfunctional adipose tissue is initially stored in the visceral depot, overflowing subsequently to produce lipotoxicity in ectopic depots like liver, heart, muscle, and pancreas, among others. People living with obesity need a diagnostic approach that considers an exhaustive pathophysiology and complications assessment. Thus, it is essential to warrant a holistic diagnosis and management that guarantees an adequate health status, and quality of life. The present review summarizes the different complications associated with obesity, at the same time, we aim to fostering a novel framework that enhances a patient-centered approach to obesity management in the precision medicine era.<\/jats:p>","DOI":"10.1007\/s11154-023-09797-2","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T01:28:38Z","timestamp":1683768518000},"page":"795-807","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Towards an adiposity-related disease framework for the diagnosis and management of obesities"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5748-0581","authenticated-orcid":false,"given":"Carolina M.","family":"Perdomo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1645-7406","authenticated-orcid":false,"given":"Ic\u00edar","family":"Avil\u00e9s-Olmos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8546-6245","authenticated-orcid":false,"given":"Dror","family":"Dicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8305-7154","authenticated-orcid":false,"given":"Gema","family":"Fr\u00fchbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,10]]},"reference":[{"key":"9797_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000497124","volume":"12","author":"G Fr\u00fchbeck","year":"2019","unstructured":"Fr\u00fchbeck G, Busetto L, Dicker D, et al. The ABCD of obesity: An EASO position statement on a diagnostic term with clinical and scientific implications. Obes Facts. 2019;12:131\u20136. https:\/\/doi.org\/10.1159\/000497124.","journal-title":"Obes Facts"},{"key":"9797_CR2","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S2213-8587(18)30288-2","volume":"6","author":"K Bhaskaran","year":"2018","unstructured":"Bhaskaran K, dos-Santos-Silva I, Leon DA, et al. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3\u00b76 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6:944\u201353. https:\/\/doi.org\/10.1016\/S2213-8587(18)30288-2.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"353","key":"9797_CR3","doi-asserted-by":"publisher","first-page":"i2156","DOI":"10.1136\/bmj.i2156","volume":"4","author":"D Aune","year":"2016","unstructured":"Aune D, Sen A, Prasad M, Norat T, Janszky I, Tonstad S, Romundstad P, Vatten LJ. BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ. 2016;4(353):i2156. https:\/\/doi.org\/10.1136\/bmj.i2156.","journal-title":"BMJ"},{"key":"9797_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2022.860799","volume":"13","author":"Y Pincu","year":"2022","unstructured":"Pincu Y, Yoel U, Haim Y, et al. Assessing obesity-related adipose tissue disease (OrAD) to improve precision medicine for patients living with obesity. Front Endocrinol (Lausanne). 2022;13:1\u201317. https:\/\/doi.org\/10.3389\/fendo.2022.860799.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9797_CR5","doi-asserted-by":"publisher","unstructured":"Hamjane N, Benyahya F, Nourouti NG, et al. Cardiovascular diseases and metabolic abnormalities associated with obesity: What is the role of inflammatory responses? A systematic review. Microvasc Res.\u00a02020;131. https:\/\/doi.org\/10.1016\/j.mvr.2020.104023.","DOI":"10.1016\/j.mvr.2020.104023"},{"key":"9797_CR6","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1056\/nejmra2032804","volume":"386","author":"AM Cypess","year":"2022","unstructured":"Cypess AM. Reassessing Human Adipose Tissue. N Engl J Med. 2022;386:768\u201379. https:\/\/doi.org\/10.1056\/nejmra2032804.","journal-title":"N Engl J Med"},{"key":"9797_CR7","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cell.2021.12.016","volume":"185","author":"A Sakers","year":"2022","unstructured":"Sakers A, De Siqueira MK, Seale P, Villanueva CJ. Adipose-tissue plasticity in health and disease. Cell. 2022;185:419\u201346. https:\/\/doi.org\/10.1016\/j.cell.2021.12.016.","journal-title":"Cell"},{"key":"9797_CR8","doi-asserted-by":"publisher","first-page":"E691","DOI":"10.1152\/ajpendo.00297.2015","volume":"309","author":"A Rodr\u00edguez","year":"2015","unstructured":"Rodr\u00edguez A, Ezquerro S, M\u00e9ndez-Gim\u00e9nez L, et al. Revisiting the adipocyte: A model for integration of cytokine signaling in the regulation of energy metabolism. Am J Physiol - Endocrinol Metab. 2015;309:E691\u2013714. https:\/\/doi.org\/10.1152\/ajpendo.00297.2015.","journal-title":"Am J Physiol - Endocrinol Metab"},{"key":"9797_CR9","doi-asserted-by":"publisher","unstructured":"Liang W, Qi Y, Yi H, et al. The roles of adipose tissue macrophages in human disease. Front Immunol. 2022;13:1\u201311. https:\/\/doi.org\/10.3389\/fimmu.2022.908749.","DOI":"10.3389\/fimmu.2022.908749"},{"key":"9797_CR10","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1007\/s00125-013-3015-9","volume":"56","author":"JM Moreno-Navarrete","year":"2013","unstructured":"Moreno-Navarrete JM, Escot\u00e9 X, Ortega F, et al. A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia. 2013;56:2524\u201337. https:\/\/doi.org\/10.1007\/s00125-013-3015-9.","journal-title":"Diabetologia"},{"key":"9797_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/eci.12997","volume":"48","author":"X Unamuno","year":"2018","unstructured":"Unamuno X, G\u00f3mez-Ambrosi J, Rodr\u00edguez A, et al. Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur J Clin Invest. 2018;48:1\u201311. https:\/\/doi.org\/10.1111\/eci.12997.","journal-title":"Eur J Clin Invest"},{"key":"9797_CR12","doi-asserted-by":"publisher","unstructured":"Lipke K, Kubis-Kubiak A, Piwowar A. Molecular mechanism of lipotoxicity as an interesting aspect in the development of pathological states\u2014current view of knowledge. Cells. 2022;11. https:\/\/doi.org\/10.3390\/cells11050844.","DOI":"10.3390\/cells11050844"},{"key":"9797_CR13","doi-asserted-by":"publisher","unstructured":"De Fano M, Bartolini D, Tortoioli C, et al. Adipose tissue plasticity in response to pathophysiological cues: A connecting link between obesity and its associated comorbidities. Int J Mol Sci.\u00a02022;23. https:\/\/doi.org\/10.3390\/ijms23105511.","DOI":"10.3390\/ijms23105511"},{"key":"9797_CR14","doi-asserted-by":"publisher","unstructured":"Nguyen Dinh Cat A, Montezano AC, Burger D, Touyz RM. Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. Antioxidants Redox Signal.\u00a02013;19:1110\u20131120. https:\/\/doi.org\/10.1089\/ars.2012.4641.","DOI":"10.1089\/ars.2012.4641"},{"key":"9797_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu11030677","volume":"11","author":"CM Perdomo","year":"2019","unstructured":"Perdomo CM, Fr\u00fchbeck G, Escalada J. Impact of nutritional changes on nonalcoholic fatty liver disease. Nutrients. 2019;11:1\u201325. https:\/\/doi.org\/10.3390\/nu11030677.","journal-title":"Nutrients"},{"key":"9797_CR16","doi-asserted-by":"publisher","unstructured":"Ferreira FG, Reitz LK, Valmorbida A, et al. Metabolically unhealthy and overweight phenotypes are associated with increased levels of inflammatory cytokines: a population-based study. Nutrition. 2022;96:111590. https:\/\/doi.org\/10.1016\/j.nut.2022.111590.","DOI":"10.1016\/j.nut.2022.111590"},{"key":"9797_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S2213-8587(17)30312-1","volume":"6","author":"G Fr\u00fchbeck","year":"2018","unstructured":"Fr\u00fchbeck G, Kiortsis DN, Catal\u00e1n V. Precision medicine: diagnosis and management of obesity. Lancet Diabetes Endocrinol. 2018;6:164\u20136. https:\/\/doi.org\/10.1016\/S2213-8587(17)30312-1.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"9797_CR18","doi-asserted-by":"publisher","first-page":"E984","DOI":"10.1161\/CIR.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley TM, Poirier P, Burke LE, et al. Obesity and cardiovascular disease a scientific statement from the American Heart Association. Circulation. 2021;143:E984\u20131010. https:\/\/doi.org\/10.1161\/CIR.0000000000000973.","journal-title":"Circulation"},{"key":"9797_CR19","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S2213-8587(18)30137-2","volume":"6","author":"N Eckel","year":"2018","unstructured":"Eckel N, Li Y, Kuxhaus O, et al. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90 257 women (the Nurses\u2019 Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 2018;6:714\u201324. https:\/\/doi.org\/10.1016\/S2213-8587(18)30137-2.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9497","key":"9797_CR20","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/S0140-6736(05)67663-5","volume":"366","author":"S Yusuf","year":"2005","unstructured":"Yusuf S, Hawken S, Ounpuu S. INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497):1640\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(05)67663-5.","journal-title":"Lancet"},{"key":"9797_CR21","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1161\/STROKEAHA.109.576967","volume":"41","author":"P Strazzullo","year":"2010","unstructured":"Strazzullo P, D\u2019Elia L, Cairella G, et al. Excess body weight and incidence of stroke: Meta-analysis of prospective studies with 2 million participants. Stroke. 2010;41:418\u201326. https:\/\/doi.org\/10.1161\/STROKEAHA.109.576967.","journal-title":"Stroke"},{"key":"9797_CR22","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1161\/STROKEAHA.120.033016","volume":"52","author":"JW Horn","year":"2021","unstructured":"Horn JW, Feng T, Morkedal B, et al. Obesity and risk for first ischemic stroke depends on metabolic syndrome: The HUNT study. Stroke. 2021;52:3555\u201361. https:\/\/doi.org\/10.1161\/STROKEAHA.120.033016.","journal-title":"Stroke"},{"key":"9797_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cpcardiol.2020.100655","volume":"46","author":"N Katta","year":"2021","unstructured":"Katta N, Loethen T, Lavie CJ, Alpert MA. Obesity and coronary heart disease: Epidemiology, pathology, and coronary artery imaging. Curr Probl Cardiol. 2021;46:11\u201320. https:\/\/doi.org\/10.1016\/j.cpcardiol.2020.100655.","journal-title":"Curr Probl Cardiol"},{"key":"9797_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40248-016-0066-z","volume":"11","author":"TT Mafort","year":"2016","unstructured":"Mafort TT, Rufino R, Costa CH, Lopes AJ. Obesity: Systemic and pulmonary complications, biochemical abnormalities, and impairment of lung function. Multidiscip Respir Med. 2016;11:1\u201311. https:\/\/doi.org\/10.1186\/s40248-016-0066-z.","journal-title":"Multidiscip Respir Med"},{"key":"9797_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1164\/rccm.200611-1717OC","volume":"175","author":"DA Beuther","year":"2007","unstructured":"Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: A meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med. 2007;175:661\u20136. https:\/\/doi.org\/10.1164\/rccm.200611-1717OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"9797_CR26","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.thromres.2011.10.019","volume":"128","author":"PD Stein","year":"2011","unstructured":"Stein PD, Matta F, Goldman J. Obesity and pulmonary embolism: The mounting evidence of risk and the mortality paradox. Thromb Res. 2011;128:518\u201323. https:\/\/doi.org\/10.1016\/j.thromres.2011.10.019.","journal-title":"Thromb Res"},{"key":"9797_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40248-019-0172-9","volume":"14","author":"MR Bonsignore","year":"2019","unstructured":"Bonsignore MR, Baiamonte P, Mazzuca E, et al. Obstructive sleep apnea and comorbidities: A dangerous liaison. Multidiscip Respir Med. 2019;14:1\u201312. https:\/\/doi.org\/10.1186\/s40248-019-0172-9.","journal-title":"Multidiscip Respir Med"},{"key":"9797_CR28","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella ME. Nonalcoholic fatty liver disease a systematic review. J Am Med Assoc. 2015;313:2263\u201373. https:\/\/doi.org\/10.1001\/jama.2015.5370.","journal-title":"J Am Med Assoc"},{"issue":"31","key":"9797_CR29","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.3748\/wjg.v22.i31.7006","volume":"22","author":"L Abenavoli","year":"2016","unstructured":"Abenavoli L, Milic N, Di Renzo L, et al. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World J Gastroenterol. 2016;22(31):7006\u201316. https:\/\/doi.org\/10.3748\/wjg.v22.i31.7006.","journal-title":"World J Gastroenterol."},{"key":"9797_CR30","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman SL, Neuschwander-Tetri BA, Rinella M, et al. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24:908\u201322. https:\/\/doi.org\/10.1038\/s41591-018-0104-9.","journal-title":"Nat Med"},{"issue":"5","key":"9797_CR31","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.amjmed.2020.01.007","volume":"133","author":"J Budd","year":"2020","unstructured":"Budd J, Cusi K. Non-alcoholic fatty liver disease: What does the primary care physician need to know? Am J Med. 2020;133(5):536\u201343. https:\/\/doi.org\/10.1016\/j.amjmed.2020.01.007.","journal-title":"Am J Med"},{"key":"9797_CR32","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"K Cusi","year":"2022","unstructured":"Cusi K, Isaacs S, Barb D, et al. American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical setting. Endocr Pract. 2022;28:528\u201362. https:\/\/doi.org\/10.1016\/j.eprac.2022.03.010.","journal-title":"Endocr Pract"},{"issue":"2","key":"9797_CR33","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","volume":"149","author":"P Angulo","year":"2015","unstructured":"Angulo P, Kleiner DE, Dam-Larsen S, et al. Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease. Gastroenterology. 2015;149(2):389\u2013397.e10. https:\/\/doi.org\/10.1053\/j.gastro.2015.04.043.","journal-title":"Gastroenterology"},{"key":"9797_CR34","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1111\/j.1572-0241.2006.00849.x","volume":"101","author":"DA Corley","year":"2006","unstructured":"Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: A systematic review and meta-analysis. Am J Gastroenterol. 2006;101:2619\u201328. https:\/\/doi.org\/10.1111\/j.1572-0241.2006.00849.x.","journal-title":"Am J Gastroenterol"},{"key":"9797_CR35","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s10654-015-0081-y","volume":"30","author":"D Aune","year":"2015","unstructured":"Aune D, Norat T, Vatten LJ. Body mass index, abdominal fatness and the risk of gallbladder disease. Eur J Epidemiol. 2015;30:1009\u201319. https:\/\/doi.org\/10.1007\/s10654-015-0081-y.","journal-title":"Eur J Epidemiol"},{"key":"9797_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S1590-8658(03)00087-2","volume":"35","author":"M Fraquelli","year":"2003","unstructured":"Fraquelli M, Pagliarulo M, Colucci A, et al. Gallbladder motility in obesity, diabetes mellitus and coeliac disease. Dig Liver Dis. 2003;35:12\u20136. https:\/\/doi.org\/10.1016\/S1590-8658(03)00087-2.","journal-title":"Dig Liver Dis"},{"key":"9797_CR37","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s10620-020-06275-6","volume":"66","author":"D Aune","year":"2021","unstructured":"Aune D, Mahamat-Saleh Y, Norat T, Riboli E. High body mass index and central adiposity is associated with increased risk of acute pancreatitis: a meta-analysis. Dig Dis Sci. 2021;66:1249\u201367. https:\/\/doi.org\/10.1007\/s10620-020-06275-6.","journal-title":"Dig Dis Sci"},{"key":"9797_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/cob.12184","volume":"7","author":"M Poddar","year":"2017","unstructured":"Poddar M, Chetty Y, Chetty VT. How does obesity affect the endocrine system? A narrative review. Clin Obes. 2017;7:136\u201344. https:\/\/doi.org\/10.1111\/cob.12184.","journal-title":"A narrative review Clin Obes"},{"key":"9797_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7861\/clinmedicine.19-1-37","volume":"19","author":"R Taylor","year":"2019","unstructured":"Taylor R. Calorie restriction for long-term remission of type 2 diabetes. Clin Med J R Coll Physicians London. 2019;19:37\u201342. https:\/\/doi.org\/10.7861\/clinmedicine.19-1-37.","journal-title":"Clin Med J R Coll Physicians London"},{"issue":"8","key":"9797_CR40","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1177\/2050640620944098","volume":"8","author":"L Kaps","year":"2020","unstructured":"Kaps L, Labenz C, Galle PR, Weinmann-menke J, Kostev K. Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease. United European Gastroenterol J. 2020;8(8):942\u20138. https:\/\/doi.org\/10.1177\/2050640620944098.","journal-title":"Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease"},{"key":"9797_CR41","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1007\/s11695-020-04601-5","volume":"30","author":"C Tuero","year":"2020","unstructured":"Tuero C, Valenti V, Rotellar F, et al. Revisiting the ghrelin changes following bariatric and metabolic surgery. Obes Surg. 2020;30:2763\u201380. https:\/\/doi.org\/10.1007\/s11695-020-04601-5.","journal-title":"Obes Surg"},{"key":"9797_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu11020454","volume":"11","author":"G Fr\u00fchbeck","year":"2019","unstructured":"Fr\u00fchbeck G, Catal\u00e1n V, Rodr\u00edguez A, et al. Adiponectin-leptin ratio is a functional biomarker of adipose tissue inflammation. Nutrients. 2019;11:1\u201313. https:\/\/doi.org\/10.3390\/nu11020454.","journal-title":"Nutrients"},{"key":"9797_CR43","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.urology.2011.09.040","volume":"79","author":"MJ Semins","year":"2012","unstructured":"Semins MJ, Shore AD, Makary MA, et al. The impact of obesity on urinary tract infection risk. Urology. 2012;79:266\u20139. https:\/\/doi.org\/10.1016\/j.urology.2011.09.040.","journal-title":"Urology"},{"key":"9797_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.urology.2018.09.012","volume":"123","author":"HH Lai","year":"2019","unstructured":"Lai HH, Helmuth ME, Smith AR. Relationship between central obesity, general obesity, overactive bladder syndrome and urinary incontinence among male and female patients seeking care for their lower urinary tract symptoms. Urology. 2019;123:34\u201343. https:\/\/doi.org\/10.1016\/j.urology.2018.09.012.","journal-title":"Urology"},{"key":"9797_CR45","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.juro.2012.11.029","volume":"189","author":"JK Parsons","year":"2013","unstructured":"Parsons JK, Sarma AV, McVary K, Wei JT. Obesity and benign prostatic hyperplasia: Clinical connections, emerging etiological paradigms and future directions. J Urol. 2013;189:102\u20136. https:\/\/doi.org\/10.1016\/j.juro.2012.11.029.","journal-title":"J Urol"},{"key":"9797_CR46","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.3109\/0886022X.2012.723777","volume":"34","author":"MH Ahmed","year":"2012","unstructured":"Ahmed MH, Ahmed HT, Khalil AA. Renal stone disease and obesity: What is important for urologists and nephrologists? Ren Fail. 2012;34:1348\u201354. https:\/\/doi.org\/10.3109\/0886022X.2012.723777.","journal-title":"Ren Fail"},{"key":"9797_CR47","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/sj.ki.5002194","volume":"72","author":"MK Sinha","year":"2007","unstructured":"Sinha MK, Collazo-Clavell ML, Rule A, et al. Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int. 2007;72:100\u20137. https:\/\/doi.org\/10.1038\/sj.ki.5002194.","journal-title":"Kidney Int"},{"key":"9797_CR48","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","volume":"144","author":"CY Hsu","year":"2006","unstructured":"Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006;144:21\u20138. https:\/\/doi.org\/10.7326\/0003-4819-144-1-200601030-00006.","journal-title":"Ann Intern Med"},{"key":"9797_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cob.12402","volume":"10","author":"WP Martin","year":"2020","unstructured":"Martin WP, Bauer J, Coleman J, et al. Obesity is common in chronic kidney disease and associates with greater antihypertensive usage and proteinuria: evidence from a cross-sectional study in a tertiary nephrology centre. Clin Obes. 2020;10:1\u201312. https:\/\/doi.org\/10.1111\/cob.12402.","journal-title":"Clin Obes"},{"key":"9797_CR50","doi-asserted-by":"publisher","first-page":"655871","DOI":"10.3389\/fmed.2021.655871","volume":"8","author":"C Garc\u00eda-Carro","year":"2021","unstructured":"Garc\u00eda-Carro C, Vergara A, Bermejo S, et al. A nephrologist perspective on obesity: from kidney injury to clinical management. Front Med. 2021;8:655871. https:\/\/doi.org\/10.3389\/fmed.2021.655871.","journal-title":"Front Med."},{"key":"9797_CR51","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/oby.2010.308","volume":"19","author":"MC Foster","year":"2011","unstructured":"Foster MC, Hwang SJ, Massaro JM, et al. Association of subcutaneous and visceral adiposity with albuminuria: The framingham heart study. Obesity. 2011;19:1284\u20139. https:\/\/doi.org\/10.1038\/oby.2010.308.","journal-title":"Obesity"},{"key":"9797_CR52","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000458467","volume":"45","author":"CP Kovesdy","year":"2017","unstructured":"Kovesdy CP, Furth SL, Zoccali C. Obesity and kidney disease: Hidden consequences of the epidemic. Am J Nephrol. 2017;45:283\u201391. https:\/\/doi.org\/10.1159\/000458467.","journal-title":"Am J Nephrol"},{"key":"9797_CR53","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.2147\/DMSO.S292926","volume":"14","author":"Y Deng","year":"2021","unstructured":"Deng Y, Zhao Q, Gong R. Association between metabolic associated fatty liver disease and chronic kidney disease: A cross-sectional study from NHANES 2017\u20132018. Diabetes, Metab Syndr Obes Targets Ther. 2021;14:1751\u201361. https:\/\/doi.org\/10.2147\/DMSO.S292926.","journal-title":"Diabetes, Metab Syndr Obes Targets Ther"},{"issue":"2","key":"9797_CR54","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/ijms21020494","volume":"21","author":"SH Hong","year":"2020","unstructured":"Hong SH, Choi KM. Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences. Int J Mol Sci. 2020;21(2):494. https:\/\/doi.org\/10.3390\/ijms21020494.","journal-title":"Int J Mol Sci"},{"key":"9797_CR55","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000521241","volume":"15","author":"LM Donini","year":"2022","unstructured":"Donini LM, Busetto L, Bischoff SC, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts. 2022;15:321\u201335. https:\/\/doi.org\/10.1159\/000521241.","journal-title":"Obes Facts"},{"key":"9797_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12891-018-2137-0","volume":"19","author":"TP Walsh","year":"2018","unstructured":"Walsh TP, Arnold JB, Evans AM, et al. The association between body fat and musculoskeletal pain: A systematic review and meta-analysis. BMC Musculoskelet Disord. 2018;19:1\u201313. https:\/\/doi.org\/10.1186\/s12891-018-2137-0.","journal-title":"BMC Musculoskelet Disord"},{"key":"9797_CR57","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/obr.12173","volume":"15","author":"H Bliddal","year":"2014","unstructured":"Bliddal H, Leeds AR, Christensen R. Osteoarthritis, obesity and weight loss: Evidence, hypotheses and horizons - a scoping review. Obes Rev. 2014;15:578\u201386. https:\/\/doi.org\/10.1111\/obr.12173.","journal-title":"Obes Rev"},{"key":"9797_CR58","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1136\/annrheumdis-2014-205459","volume":"73","author":"B Lu","year":"2014","unstructured":"Lu B, Hiraki LT, Sparks JA, et al. Being overweight or obese and risk of developing rheumatoid arthritis among women: A prospective cohort study. Ann Rheum Dis. 2014;73:1914\u201322. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205459.","journal-title":"Ann Rheum Dis"},{"key":"9797_CR59","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/acr.20479","volume":"63","author":"MAMA DeMarco","year":"2011","unstructured":"DeMarco MAMA, Maynard JW, Huizinga MM, et al. Obesity and younger age at gout onset in a community-based cohort. Arthritis Care Res. 2011;63:1108\u201314. https:\/\/doi.org\/10.1002\/acr.20479.","journal-title":"Arthritis Care Res"},{"key":"9797_CR60","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1136\/annrheumdis-2017-211472","volume":"76","author":"SM Nielsen","year":"2017","unstructured":"Nielsen SM, Bartels EM, Henriksen M, et al. Weight loss for overweight and obese individuals with gout: A systematic review of longitudinal studies. Ann Rheum Dis. 2017;76:1870\u201382. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211472.","journal-title":"Ann Rheum Dis"},{"key":"9797_CR61","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1038\/s41380-022-01604-9","volume":"27","author":"Y-T Deng","year":"2022","unstructured":"Deng Y-T, Li Y-Z, Huang S-Y, et al. Association of life course adiposity with risk of incident dementia: a prospective cohort study of 322,336 participants. Mol Psychiatry. 2022;27:3385\u201395. https:\/\/doi.org\/10.1038\/s41380-022-01604-9.","journal-title":"Mol Psychiatry"},{"key":"9797_CR62","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.3389\/fpsyg.2019.02126","volume":"10","author":"F Favieri","year":"2019","unstructured":"Favieri F, Forte G, Casagrande M. The Executive Functions in Overweight and Obesity: A Systematic Review of Neuropsychological Cross-Sectional and Longitudinal Studies. Front Psychol. 2019;10:2126. https:\/\/doi.org\/10.3389\/fpsyg.2019.02126.","journal-title":"Front Psychol"},{"key":"9797_CR63","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/obr.12799","volume":"20","author":"MJ Herrmann","year":"2019","unstructured":"Herrmann MJ, Tesar A, Beier J, et al. Grey matter alterations in obesity: A meta-analysis of whole-brain studies. Obes Rev. 2019;20:464\u201371. https:\/\/doi.org\/10.1111\/obr.12799.","journal-title":"Obes Rev"},{"key":"9797_CR64","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.bbi.2014.04.001","volume":"42","author":"AA Miller","year":"2014","unstructured":"Miller AA, Spencer SJ. Obesity and neuroinflammation: A pathway to cognitive impairment. Brain Behav Immun. 2014;42:10\u201321. https:\/\/doi.org\/10.1016\/j.bbi.2014.04.001.","journal-title":"Brain Behav Immun"},{"key":"9797_CR65","doi-asserted-by":"publisher","first-page":"176","DOI":"10.21037\/atm.2018.04.22","volume":"6","author":"J-W Li","year":"2018","unstructured":"Li J-W, Zong Y, Cao X-P, et al. Microglial priming in Alzheimer\u2019s disease. Ann Transl Med. 2018;6:176. https:\/\/doi.org\/10.21037\/atm.2018.04.22.","journal-title":"Ann Transl Med"},{"key":"9797_CR66","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.3390\/nu10111681","volume":"10","author":"J Zhou","year":"2018","unstructured":"Zhou J, Mao L, Xu P, Wang Y. Effects of epigallocatechin gallate (EGCG) on energy expenditure and microglia-mediated hypothalamic inflammation in mice fed a high-fat diet. Nutrients. 2018;10:1681. https:\/\/doi.org\/10.3390\/nu10111681.","journal-title":"Nutrients"},{"key":"9797_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnint.2022.798995","volume":"16","author":"V Salas-Venegas","year":"2022","unstructured":"Salas-Venegas V, Flores-Torres RP, Rodr\u00edguez-Cort\u00e9s YM, et al. The obese brain: Mechanisms of systemic and local inflammation, and interventions to reverse the cognitive deficit. Front Integr Neurosci. 2022;16:1\u201319. https:\/\/doi.org\/10.3389\/fnint.2022.798995.","journal-title":"Front Integr Neurosci"},{"key":"9797_CR68","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.3390\/ijms23073508","volume":"23","author":"R Moretti","year":"2022","unstructured":"Moretti R, Caruso P. Small vessel disease: Ancient description,\u00a0novel biomarkers. Int J Mol Sci. 2022;23:3508. https:\/\/doi.org\/10.3390\/ijms23073508.","journal-title":"Int J Mol Sci"},{"key":"9797_CR69","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s10194-021-01337-0","volume":"22","author":"CSJ Westgate","year":"2021","unstructured":"Westgate CSJ, Israelsen IME, Jensen RH, Eftekhari S. Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension. J Headache Pain. 2021;22:123. https:\/\/doi.org\/10.1186\/s10194-021-01337-0.","journal-title":"J Headache Pain"},{"key":"9797_CR70","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1526-4610.2009.01554.x","volume":"50","author":"BL Peterlin","year":"2010","unstructured":"Peterlin BL, Rapoport AM, Kurth T. Migraine and obesity: Epidemiology, mechanisms, and implications. Headache J Head Face Pain. 2010;50:631\u201348. https:\/\/doi.org\/10.1111\/j.1526-4610.2009.01554.x.","journal-title":"Headache J Head Face Pain"},{"key":"9797_CR71","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1001\/jamaneurol.2016.3745","volume":"73","author":"BC Callaghan","year":"2016","unstructured":"Callaghan BC, Xia R, Reynolds E, et al. Association between metabolic syndrome components and polyneuropathy in an obese population. JAMA Neurol. 2016;73:1468. https:\/\/doi.org\/10.1001\/jamaneurol.2016.3745.","journal-title":"JAMA Neurol"},{"key":"9797_CR72","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1161\/HYPERTENSIONAHA.110.155663","volume":"56","author":"E Lambert","year":"2010","unstructured":"Lambert E, Sari CI, Dawood T, et al. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension. 2010;56:351\u20138. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.155663.","journal-title":"Hypertension"},{"key":"9797_CR73","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ecl.2016.04.016","volume":"45","author":"DB Sarwer","year":"2016","unstructured":"Sarwer DB, Polonsky HM. The psychosocial burden of obesity. Endocrinol Metab Clin North Am. 2016;45:677\u201388. https:\/\/doi.org\/10.1016\/j.ecl.2016.04.016.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"9797_CR74","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/osp4.518","volume":"7","author":"F Rubino","year":"2021","unstructured":"Rubino F, Logue J, B\u00f8gelund M, et al. Attitudes about the treatment of obesity among healthcare providers involved in the care of obesity-related diseases: A survey across medical specialties in multiple European countries. Obes Sci Pract. 2021;7:659\u201368. https:\/\/doi.org\/10.1002\/osp4.518.","journal-title":"Obes Sci Pract"},{"key":"9797_CR75","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/jan.13511","volume":"74","author":"YK Wu","year":"2018","unstructured":"Wu YK, Berry DC. Impact of weight stigma on physiological and psychological health outcomes for overweight and obese adults: A systematic review. J Adv Nurs. 2018;74:1030\u201342. https:\/\/doi.org\/10.1111\/jan.13511.","journal-title":"J Adv Nurs"},{"key":"9797_CR76","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41591-020-0803-x","volume":"26","author":"F Rubino","year":"2020","unstructured":"Rubino F, Puhl RM, Cummings DE, et al. Joint international consensus statement for ending stigma of obesity. Nat Med. 2020;26:485\u201397. https:\/\/doi.org\/10.1038\/s41591-020-0803-x.","journal-title":"Nat Med"},{"key":"9797_CR77","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1159\/000454837","volume":"9","author":"NA Weinberger","year":"2017","unstructured":"Weinberger NA, Kersting A, Riedel-Heller SG, Luck-Sikorski C. Body dissatisfaction in individuals with obesity compared to normal-weight individuals: A systematic review and meta-analysis. Obes Facts. 2017;9:424\u201341. https:\/\/doi.org\/10.1159\/000454837.","journal-title":"Obes Facts"},{"issue":"4","key":"9797_CR78","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.cnur.2021.07.010","volume":"56","author":"C Perry","year":"2021","unstructured":"Perry C, Guillory TS, Dilks SS. Obesity and psychiatric disorders. Nurs Clin North Am. 2021;56(4):553\u201363. https:\/\/doi.org\/10.1016\/j.cnur.2021.07.010.","journal-title":"Nurs Clin North Am"},{"key":"9797_CR79","unstructured":"WHO European Regional Obesity Report 2022. Copenhagen: WHO Regional Office for Europe.\u00a02022. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"9797_CR80","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.metabol.2018.11.001","volume":"92","author":"KI Avgerinos","year":"2019","unstructured":"Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M. Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism. 2019;92:121\u201335. https:\/\/doi.org\/10.1016\/j.metabol.2018.11.001.","journal-title":"Metabolism"},{"key":"9797_CR81","doi-asserted-by":"publisher","unstructured":"Catal\u00e1n V, G\u00f3mez-Ambrosi J, Rodr\u00edguez A, Fr\u00fchbeck G. Adipose tissue immunity and cancer. Front Physiol. 2013;1\u201313. https:\/\/doi.org\/10.3389\/fphys.2013.00275.","DOI":"10.3389\/fphys.2013.00275"},{"key":"9797_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2014.00065","volume":"5","author":"AI P\u00e9rez-Hern\u00e1ndez","year":"2014","unstructured":"P\u00e9rez-Hern\u00e1ndez AI, Catal\u00e1n V, G\u00f3mez-Ambrosi J, et al. Mechanisms linking excess adiposity and carcinogenesis promotion. Front Endocrinol (Lausanne). 2014;5:1\u201317. https:\/\/doi.org\/10.3389\/fendo.2014.00065.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9797_CR83","doi-asserted-by":"publisher","unstructured":"Y\u00e1rnoz-Esquiroz P, Olazar\u00e1n L, Aguas-Ayesa M, et al. \u2018Obesities\u2019: Position statement on a complex disease entity with multifaceted drivers. Eur J Clin Invest. 2022;52. https:\/\/doi.org\/10.1111\/eci.13811.","DOI":"10.1111\/eci.13811"},{"key":"9797_CR84","doi-asserted-by":"publisher","unstructured":"Pich\u00e9 ME, Tchernof A, Despr\u00e9s JP. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res 2020:1477\u20131500. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.316101.","DOI":"10.1161\/CIRCRESAHA.120.316101"},{"key":"9797_CR85","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1161\/circulationaha.117.029617","volume":"137","author":"IJ Neeland","year":"2018","unstructured":"Neeland IJ, Poirier P, Despr\u00e9s J-P. Cardiovascular and metabolic heterogeneity of obesity. Circulation. 2018;137:1391\u2013406. https:\/\/doi.org\/10.1161\/circulationaha.117.029617.","journal-title":"Circulation"},{"key":"9797_CR86","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1467-789X.2012.01051.x","volume":"14","author":"AJ Cameron","year":"2013","unstructured":"Cameron AJ, Magliano DJ, S\u00f6derberg S. A systematic review of the impact of including both waist and hip circumference in risk models for cardiovascular diseases, diabetes and mortality. Obes Rev. 2013;14:86\u201394. https:\/\/doi.org\/10.1111\/j.1467-789X.2012.01051.x.","journal-title":"Obes Rev"},{"key":"9797_CR87","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","volume":"16","author":"R Ross","year":"2020","unstructured":"Ross R, Neeland IJ, Yamashita S, et al. Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on visceral obesity. Nat Rev Endocrinol. 2020;16:177\u201389. https:\/\/doi.org\/10.1038\/s41574-019-0310-7.","journal-title":"Nat Rev Endocrinol"},{"key":"9797_CR88","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.clnu.2017.11.012","volume":"38","author":"FS Diemer","year":"2019","unstructured":"Diemer FS, Brewster LM, Haan YC, Oehlers GP, van Montfrans GA, Nahar-van Venrooij LMW. Body composition measures and cardiovascular risk in high-risk ethnic groups. Clin Nutr. 2019;38:450\u20136. https:\/\/doi.org\/10.1016\/j.clnu.2017.11.012.","journal-title":"Clin Nutr"},{"key":"9797_CR89","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","volume":"13","author":"M Ashwell","year":"2012","unstructured":"Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: Systematic review and meta-analysis. Obes Rev. 2012;13:275\u201386. https:\/\/doi.org\/10.1111\/j.1467-789X.2011.00952.x.","journal-title":"Obes Rev"},{"key":"9797_CR90","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1017\/S0007114519003301","volume":"123","author":"S Gibson","year":"2020","unstructured":"Gibson S, Ashwell M. A simple cut-off for waist-to-height ratio (0\u00b75) can act as an indicator for cardiometabolic risk: Recent data from adults in the Health Survey for England. Br J Nutr. 2020;123:681\u201390. https:\/\/doi.org\/10.1017\/S0007114519003301.","journal-title":"Br J Nutr"},{"key":"9797_CR91","doi-asserted-by":"publisher","unstructured":"Chen N, Hu LK, Sun Y, et al. Associations of waist-to-height ratio with the incidence of type 2 diabetes and mediation analysis: Two independent cohort studies. Obes Res Clin Pract. 2023:1\u20137. https:\/\/doi.org\/10.1016\/j.orcp.2022.12.005.","DOI":"10.1016\/j.orcp.2022.12.005"},{"key":"9797_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcvm.2020.00022","volume":"7","author":"A Chait","year":"2020","unstructured":"Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med. 2020;7:1\u201341. https:\/\/doi.org\/10.3389\/fcvm.2020.00022.","journal-title":"Front Cardiovasc Med"},{"key":"9797_CR93","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1007\/s00125-012-2639-5","volume":"55","author":"BM Kaess","year":"2012","unstructured":"Kaess BM, Pedley A, Massaro JM, et al. The ratio of visceral to subcutaneous fat, a metric of body fat distribution, is a unique correlate of cardiometabolic risk. Diabetologia. 2012;55:2622\u201330. https:\/\/doi.org\/10.1007\/s00125-012-2639-5.","journal-title":"Diabetologia"},{"key":"9797_CR94","doi-asserted-by":"publisher","first-page":"100097","DOI":"10.1016\/j.ajpc.2020.100097","volume":"4","author":"EC Aneni","year":"2020","unstructured":"Aneni EC, Bittencourt MS, Teng C, et al. The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: A longitudinal study. Am J Prev Cardiol. 2020;4:100097. https:\/\/doi.org\/10.1016\/j.ajpc.2020.100097.","journal-title":"Am J Prev Cardiol."},{"key":"9797_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-021-01420-5","volume":"20","author":"E Cosson","year":"2021","unstructured":"Cosson E, Nguyen MT, Rezgani I, et al. Epicardial adipose tissue volume and myocardial ischemia in asymptomatic people living with diabetes: a cross-sectional study. Cardiovasc Diabetol. 2021;20:1\u201310. https:\/\/doi.org\/10.1186\/s12933-021-01420-5.","journal-title":"Cardiovasc Diabetol"},{"key":"9797_CR96","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/j.1467-789X.2010.00766.x","volume":"11","author":"AM Sharma","year":"2010","unstructured":"Sharma AM. M, M, M & M: A mnemonic for assessing obesity. Obes Rev. 2010;11:808\u20139. https:\/\/doi.org\/10.1111\/j.1467-789X.2010.00766.x.","journal-title":"Obes Rev"},{"key":"9797_CR97","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0009-9120(02)00320-X","volume":"35","author":"J G\u00f3mez-Ambrosi","year":"2002","unstructured":"G\u00f3mez-Ambrosi J, Salvador J, P\u00e1ramo JA, et al. Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clin Biochem. 2002;35:315\u201320. https:\/\/doi.org\/10.1016\/S0009-9120(02)00320-X.","journal-title":"Clin Biochem"},{"key":"9797_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-06997-0","volume":"7","author":"G Fr\u00fchbeck","year":"2017","unstructured":"Fr\u00fchbeck G, Catal\u00e1n V, Rodr\u00edguez A, et al. Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome. Sci Rep. 2017;7:1\u20138. https:\/\/doi.org\/10.1038\/s41598-017-06997-0.","journal-title":"Sci Rep"},{"key":"9797_CR99","doi-asserted-by":"publisher","unstructured":"Ghantous CM, Azrak Z, Hanache S, et al. Differential role of leptin and adiponectin in cardiovascular system. Int J Endocrinol. 2015;534320.\u00a0https:\/\/doi.org\/10.1155\/2015\/534320.","DOI":"10.1155\/2015\/534320"},{"key":"9797_CR100","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/21623945.2017.1402151","volume":"7","author":"G Fr\u00fchbeck","year":"2018","unstructured":"Fr\u00fchbeck G, Catal\u00e1n V, Rodr\u00edguez A, G\u00f3mez-Ambrosi J. Adiponectin-leptin ratio: A promising index to estimate adipose tissue dysfunction.\u00a0Relation with obesity-associated cardiometabolic risk. Adipocyte. 2018;7:57\u201362. https:\/\/doi.org\/10.1080\/21623945.2017.1402151.","journal-title":"Adipocyte"},{"key":"9797_CR101","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu11112664","volume":"11","author":"MF Landecho","year":"2019","unstructured":"Landecho MF, Tuero C, Valent\u00ed V, et al. Relevance of leptin and other adipokines in obesity-associated cardiovascular risk. Nutrients. 2019;11:1\u201316. https:\/\/doi.org\/10.3390\/nu11112664.","journal-title":"Nutrients"},{"key":"9797_CR102","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2119\/molmed.2011.00144","volume":"17","author":"V Catal\u00e1n","year":"2011","unstructured":"Catal\u00e1n V, G\u00f3mez-Ambrosi J, Rodr\u00edguez A, et al. Increased levels of calprotectin in obesity are related to macrophage content: Impact on inflammation and effect of weight loss. Mol Med. 2011;17:1157\u201367. https:\/\/doi.org\/10.2119\/molmed.2011.00144.","journal-title":"Mol Med"},{"key":"9797_CR103","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1210\/jc.2010-0630","volume":"95","author":"M Sabater","year":"2010","unstructured":"Sabater M, Moreno-Navarrete JM, Ortega FJ, et al. Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss. J Clin Endocrinol Metab. 2010;95:4720\u20138. https:\/\/doi.org\/10.1210\/jc.2010-0630.","journal-title":"J Clin Endocrinol Metab"},{"key":"9797_CR104","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1007\/s00125-012-2671-5","volume":"55","author":"A Rodr\u00edguez","year":"2012","unstructured":"Rodr\u00edguez A, G\u00f3mez-Ambrosi J, Catal\u00e1n V, et al. The ghrelin O-Acyltransferase-Ghrelin system reduces TNF-\u03b1-Induced apoptosis and autophagy in human visceral adipocytes. Diabetologia. 2012;55:3038\u201350. https:\/\/doi.org\/10.1007\/s00125-012-2671-5.","journal-title":"Diabetologia"},{"key":"9797_CR105","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/438436b","volume":"438","author":"FG Obesity","year":"2005","unstructured":"Obesity FG. Aquaporin enters the picture. Nature. 2005;438:436\u20137. https:\/\/doi.org\/10.1038\/438436b.","journal-title":"Nature"},{"key":"9797_CR106","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.mce.2014.06.017","volume":"397","author":"L M\u00e9ndez-Gim\u00e9nez","year":"2014","unstructured":"M\u00e9ndez-Gim\u00e9nez L, Rodr\u00edguez A, Balaguer I, Fr\u00fchbeck G. Role of aquaglyceroporins and caveolins in energy and metabolic homeostasis. Mol Cell Endocrinol. 2014;397:78\u201392. https:\/\/doi.org\/10.1016\/j.mce.2014.06.017.","journal-title":"Mol Cell Endocrinol"},{"key":"9797_CR107","doi-asserted-by":"publisher","unstructured":"Lombardi R, Airaghi L, Targher G, et al. Liver fibrosis by FibroScan independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes. Liver Int. 2020:347\u201354. https:\/\/doi.org\/10.1111\/liv.14274.","DOI":"10.1111\/liv.14274"},{"key":"9797_CR108","doi-asserted-by":"publisher","unstructured":"Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005:1313\u201321. https:\/\/doi.org\/10.1002\/hep.20701.","DOI":"10.1002\/hep.20701"},{"issue":"6","key":"9797_CR109","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325. https:\/\/doi.org\/10.1002\/hep.21178.","journal-title":"Hepatology"},{"issue":"3","key":"9797_CR110","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, et al. Nonalcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis of observational studies. J Hepatol. 2016;65(3):589\u2013600. https:\/\/doi.org\/10.1016\/j.jhep.2016.05.013.","journal-title":"J Hepatol"},{"key":"9797_CR111","doi-asserted-by":"publisher","unstructured":"Perdomo CM, Ezponda A, C\u00f3rdoba JMN, Herrero JI, Bastarrika G, Fr\u00fchbeck G, et al. Transient elastography and serum markers of liver fibrosis associate with epicardial adipose tissue and coronary artery calcium in NAFLD. Sci Rep. 2022:1\u201310. https:\/\/doi.org\/10.1038\/s41598-022-10487-3.","DOI":"10.1038\/s41598-022-10487-3"},{"issue":"4","key":"9797_CR112","doi-asserted-by":"publisher","first-page":"e92772","DOI":"10.1371\/journal.pone.0092772","volume":"9","author":"Q Xie","year":"2014","unstructured":"Xie Q, Zhou X, Huang P, et al. The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: A meta-analysis. PLoS One. 2014;9(4):e92772. https:\/\/doi.org\/10.1371\/journal.pone.0092772.","journal-title":"PLoS One"},{"key":"9797_CR113","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1210\/jc.2017-00138","volume":"102","author":"PB Lassen","year":"2017","unstructured":"Lassen PB, Charlotte F, Liu Y, et al. The fat score, a fibrosis score of adipose tissue: Predicting weight-loss outcome after gastric bypass. J Clin Endocrinol Metab. 2017;102:2443\u201353. https:\/\/doi.org\/10.1210\/jc.2017-00138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9797_CR114","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.3390\/cells9061508","volume":"9","author":"N Goldstein","year":"2020","unstructured":"Goldstein N, Kezerle Y, Gepner Y, et al. Higher mast cell accumulation in human adipose tissues defines clinically favorable obesity sub-phenotypes. Cells. 2020;9(6):1508. https:\/\/doi.org\/10.3390\/cells9061508.","journal-title":"Cells."},{"key":"9797_CR115","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1210\/jc.2014-1074","volume":"99","author":"A Cotillard","year":"2014","unstructured":"Cotillard A, Poitou C, Torcivia A, et al. Adipocyte size threshold matters: Link with risk of type 2 diabetes and improved insulin resistance after gastric bypass. J Clin Endocrinol Metab. 2014;99:1466\u201370. https:\/\/doi.org\/10.1210\/jc.2014-1074.","journal-title":"J Clin Endocrinol Metab"},{"key":"9797_CR116","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1096\/fj.00-0249com","volume":"15","author":"G Fr\u00fchbeck","year":"2001","unstructured":"Fr\u00fchbeck G, G\u00f3mez-Ambrosi J, Salvador J. Leptin-induced lipolysis opposes the tonic inhibition of endogenous adenosine in white adipocytes. FASEB J. 2001;15:333\u201340. https:\/\/doi.org\/10.1096\/fj.00-0249com.","journal-title":"FASEB J"},{"key":"9797_CR117","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0898-6568(01)00211-X","volume":"13","author":"G Fr\u00fchbeck","year":"2001","unstructured":"Fr\u00fchbeck G, G\u00f3mez-Ambrosi J. Modulation of the leptin-induced white adipose tissue lipolysis by nitric oxide. Cell Signal. 2001;13:827\u201333. https:\/\/doi.org\/10.1016\/S0898-6568(01)00211-X.","journal-title":"Cell Signal"},{"key":"9797_CR118","doi-asserted-by":"publisher","unstructured":"Pulido MR, Diaz-Ruiz A, Jim\u00e9nez-G\u00f3mez Y, et al. Rab18 dynamics in adipocytes in relation to lipogenesis, lipolysis and obesity. PLoS One. 2011;6. https:\/\/doi.org\/10.1371\/journal.pone.0022931.","DOI":"10.1371\/journal.pone.0022931"},{"key":"9797_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/ajpregu.00926.2007","volume":"295","author":"O Poulain-Godefroy","year":"2008","unstructured":"Poulain-Godefroy O, Lecoeur C, Pattou F, et al. Inflammation is associated with a decrease of lipogenic factors in omental fat in women. Am J Physiol. 2008;295:1\u20137. https:\/\/doi.org\/10.1152\/ajpregu.00926.2007.","journal-title":"Am J Physiol"},{"key":"9797_CR120","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","volume":"1","author":"N Stefan","year":"2013","unstructured":"Stefan N, H\u00e4ring HU, Hu FB, Schulze MB. Metabolically healthy obesity: Epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013;1:152\u201362. https:\/\/doi.org\/10.1016\/S2213-8587(13)70062-7.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"9797_CR121","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1007\/s00125-021-05484-6","volume":"64","author":"Z Zhou","year":"2021","unstructured":"Zhou Z, Macpherson J, Gray SR, Gill JMR, Welsh P, Celis-Morales C, et al. Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants. Diabetologia. 2021;64:1963\u201372. https:\/\/doi.org\/10.1007\/s00125-021-05484-6.","journal-title":"Diabetologia"},{"issue":"9","key":"9797_CR122","doi-asserted-by":"publisher","first-page":"1023583","DOI":"10.3389\/fmed.2022.1023583","volume":"20","author":"CM Perdomo","year":"2022","unstructured":"Perdomo CM, N\u00fa\u00f1ez-C\u00f3rdoba JM, Ezponda A, et al. Cardiometabolic characterization in metabolic dysfunction-associated fatty liver disease. Front Med (Lausanne). 2022;20(9):1023583. https:\/\/doi.org\/10.3389\/fmed.2022.1023583.","journal-title":"Front Med (Lausanne)"},{"key":"9797_CR123","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.2337\/dc14-0937","volume":"37","author":"J G\u00f3mez-Ambrosi","year":"2014","unstructured":"G\u00f3mez-Ambrosi J, Catal\u00e1n V, Rodr\u00edguez A, et al. Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy. Diabetes Care. 2014;37:2813\u201321. https:\/\/doi.org\/10.2337\/dc14-0937.","journal-title":"Diabetes Care"},{"key":"9797_CR124","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ijo.2011.247","volume":"36","author":"Y Chang","year":"2012","unstructured":"Chang Y, Ryu S, Suh BS, et al. Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men. Int J Obes. 2012;36:1187\u201394. https:\/\/doi.org\/10.1038\/ijo.2011.247.","journal-title":"Int J Obes"},{"key":"9797_CR125","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1096\/fj.09-133058","volume":"24","author":"M L\u00f6nn","year":"2010","unstructured":"L\u00f6nn M, Mehlig K, Bengtsson C, Lissner L. Adipocyte size predicts incidence of type 2 diabetes in women. FASEB J. 2010;24:326\u201331. https:\/\/doi.org\/10.1096\/fj.09-133058.","journal-title":"FASEB J"},{"key":"9797_CR126","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1007\/s001250051560","volume":"43","author":"C Weyer","year":"2000","unstructured":"Weyer C, Foley JE, Borgadus C, et al. Enlarged subcutaneous adbominal adipocyte size, but not obesity itself, predicts Type II diabetes independent of insulin resistance. Diabetologia. 2000;43:1498\u2013506. https:\/\/doi.org\/10.1007\/s001250051560. PMID: 11151758.","journal-title":"Diabetologia"},{"key":"9797_CR127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-021-00754-1","volume":"21","author":"D El\u00edas-L\u00f3pez","year":"2021","unstructured":"El\u00edas-L\u00f3pez D, Vargas-V\u00e1zquez A, Mehta R, et al. Natural course of metabolically healthy phenotype and risk of developing Cardiometabolic diseases: a three years follow-up study. BMC Endocr Disord. 2021;21:1\u201312. https:\/\/doi.org\/10.1186\/s12902-021-00754-1.","journal-title":"BMC Endocr Disord"},{"key":"9797_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0239164","volume":"15","author":"F Hosseinpanah","year":"2020","unstructured":"Hosseinpanah F, Tasdighi E, Barzin M, et al. The association between transition from metabolically healthy obesity to metabolic syndrome, and incidence of cardiovascular disease: Tehran lipid and glucose study. PLoS One. 2020;15:1\u201313. https:\/\/doi.org\/10.1371\/journal.pone.0239164.","journal-title":"PLoS One"},{"key":"9797_CR129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mnfr.201700594","volume":"62","author":"S Giardina","year":"2018","unstructured":"Giardina S, Hern\u00e1ndez-Alonso P, Salas-Salvad\u00f3 J, et al. Modulation of human subcutaneous adipose tissue MicroRNA profile associated with changes in adiposity-related parameters. Mol Nutr Food Res. 2018;62:1\u201324. https:\/\/doi.org\/10.1002\/mnfr.201700594.","journal-title":"Mol Nutr Food Res"},{"key":"9797_CR130","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1373\/clinchem.2012.195776","volume":"59","author":"FJ Ortega","year":"2013","unstructured":"Ortega FJ, Mercader JM, Catal\u00e1n V, et al. Targeting the circulating microRNA signature of obesity. Clin Chem. 2013;59:781\u201392. https:\/\/doi.org\/10.1373\/clinchem.2012.195776.","journal-title":"Clin Chem"},{"key":"9797_CR131","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.orcp.2018.06.005","volume":"12","author":"CH Liao","year":"2018","unstructured":"Liao CH, Wang CY, Liu KH, et al. MiR-122 marks the differences between subcutaneous and visceral adipose tissues and associates with the outcome of bariatric surgery. Obes Res Clin Pract. 2018;12:570\u20137. https:\/\/doi.org\/10.1016\/j.orcp.2018.06.005.","journal-title":"Obes Res Clin Pract"},{"key":"9797_CR132","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41574-018-0148-4","volume":"15","author":"MA van Baak","year":"2019","unstructured":"van Baak MA, Mariman ECM. Mechanisms of weight regain after weight loss \u2014 the role of adipose tissue. Nat Rev Endocrinol. 2019;15:274\u201387. https:\/\/doi.org\/10.1038\/s41574-018-0148-4.","journal-title":"Nat Rev Endocrinol"},{"key":"9797_CR133","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/S0140-6736(22)02403-5","volume":"401","author":"CM Perdomo","year":"2023","unstructured":"Perdomo CM, Cohen RV, Sumithran P, Cl\u00e9ment K, Fr\u00fchbeck G. Contemporary medical, device, and surgical therapies for obesity in adults. Lancet. 2023;401:1116\u201330.","journal-title":"Lancet."},{"key":"9797_CR134","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s11695-021-05884-y","volume":"32","author":"W Elhag","year":"2022","unstructured":"Elhag W, El Ansari W. Effectiveness and safety of liraglutide in managing inadequate weight loss and weight regain after primary and revisional bariatric surgery: anthropometric and cardiometabolic outcomes. Obes Surg. 2022;32:1005\u201315. https:\/\/doi.org\/10.1007\/s11695-021-05884-y.","journal-title":"Obes Surg"},{"key":"9797_CR135","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.gie.2020.10.016","volume":"93","author":"D Badurdeen","year":"2021","unstructured":"Badurdeen D, Hoff AC, Hedjoudje A, et al. Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty alone for weight loss. Gastrointest Endosc. 2021;93:1316-1324.e1. https:\/\/doi.org\/10.1016\/j.gie.2020.10.016.","journal-title":"Gastrointest Endosc"},{"key":"9797_CR136","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s11695-017-2986-x","volume":"28","author":"VO Brunaldi","year":"2018","unstructured":"Brunaldi VO, Jirapinyo P, de Moura DTH, et al. Endoscopic treatment of weight regain following roux-en-Y gastric bypass: a systematic review and meta-analysis. Obes Surg. 2018;28:266\u201376. https:\/\/doi.org\/10.1007\/s11695-017-2986-x.","journal-title":"Obes Surg"},{"key":"9797_CR137","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/obr.12889","volume":"20","author":"T Semlitsch","year":"2019","unstructured":"Semlitsch T, Stigler FL, Jeitler K, et al. Management of overweight and obesity in primary care\u2014A systematic overview of international evidence-based guidelines. Obes Rev. 2019;20:1218\u201330. https:\/\/doi.org\/10.1111\/obr.12889.","journal-title":"Obes Rev"},{"key":"9797_CR138","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/oby.23120","volume":"29","author":"A Acosta","year":"2021","unstructured":"Acosta A, Camilleri M, Abu Dayyeh B, et al. Selection of antiobesity medications based on phenotypes enhances weight loss: A pragmatic trial in an obesity clinic. Obesity. 2021;29:662\u201371. https:\/\/doi.org\/10.1002\/oby.23120.","journal-title":"Obesity"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-023-09797-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-023-09797-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-023-09797-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T02:18:00Z","timestamp":1694225880000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-023-09797-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,10]]},"references-count":138,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["9797"],"URL":"https:\/\/doi.org\/10.1007\/s11154-023-09797-2","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,10]]},"assertion":[{"value":"10 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"DD reports speaker and Advisory fee from: Novonordisk, Lilly, BI, Astra Zenca. CMP reports speaker fees from Novo Nordisk. GF reports research grants paid to her Institution from the Carlos III Health Institute. GF reports payment or honoraria for attendance to the 2022 Lilly Diabetes Global Medical Affairs Portfolio Advisory Board. GF is member of the OPEN Spain Initiative. GF is a co-chair of the Scientific Advisory Board of the European Association for the Study of Obesity\u2014it is an unpaid position.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial or non-financial interests"}}]}}